Id IUPAC Composition Core Glycan Type GlyTouCan UniCarb-DB Cartoon Biological associations
25 Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Glc Hex:3 HexNAc:1 dHex:2 Lactose Free G50540JU structure 25

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

212 Gal(b1-4)GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]Gal(b1-4)Glc Hex:4 HexNAc:2 Lactose Free G54021WX structure 212

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

544 Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]Glc Hex:2 dHex:2 Lactose Free G97953NC structure 544

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

660 Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc Hex:3 HexNAc:1 Lactose Free G45827GY structure 660

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

665 NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc Hex:1 HexNAc:1 dHex:1 NeuAc:1 Lactosamine Free G81971FM

316

structure 665
666 Fuc(a1-4)[Gal(b1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]Glc Hex:3 HexNAc:1 dHex:2 Lactose Free G70115XG structure 666

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

734 Fuc(a1-2)Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-3)Gal(b1-3)Glc Hex:3 HexNAc:1 dHex:1 NeuAc:1 No-core Free G50251EH structure 734

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

911 Gal(b1-3)Gal(b1-4)Glc Hex:3 Lactose Free G18315LD structure 911

    Protein

    Composition

  • Hex:3 (avg mass : 504.4425 )

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

933 NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)]Gal(b1-4)Glc Hex:4 HexNAc:2 dHex:2 NeuAc:1 Lactose Free G08431YY structure 933

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

1084 Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)]Gal(b1-4)Glc Hex:5 HexNAc:3 dHex:1 NeuAc:1 Lactose Free G98419BR structure 1084

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

1099 NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]Gal(b1-4)Glc Hex:4 HexNAc:2 dHex:1 NeuAc:1 Lactose Free G23333KI structure 1099

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

1109 Fuc(a1-4)[Gal(b1-3)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)]Gal(b1-4)Glc Hex:5 HexNAc:3 dHex:2 NeuAc:1 Lactose Free G40103VO structure 1109

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

1144 Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]Gal(b1-4)Glc Hex:4 HexNAc:1 Lactose Free G46271TS structure 1144

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

1284 NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]Glc Hex:2 dHex:1 NeuAc:1 Lactose Free G32685CP structure 1284
1446 Gal(b1-?)[Fuc(a1-?)]GlcNAc(b1-3)Gal(b1-4)Glc Hex:3 HexNAc:1 dHex:1 Lactose Free G77079RV structure 1446

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

1517 NeuAc(a2-6)Gal(b1-4)Glc Hex:2 NeuAc:1 Lactose Free G69893KP structure 1517

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

1650 Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)[Gal(b1-3)GlcNAc(b1-3)]Gal(b1-4)Glc Hex:4 HexNAc:2 dHex:1 Lactose Free G58399HX structure 1650

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

1701 Fuc(a1-?)[Gal(b1-?)]GlcNAc(b1-3)Gal(b1-4)Glc Hex:3 HexNAc:1 dHex:1 Lactose Free G77079RV structure 1701

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

1825 NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-6)]Gal(b1-4)Glc Hex:4 HexNAc:2 dHex:1 NeuAc:2 Lactose Free G40737EA structure 1825

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

1871 NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc Hex:3 HexNAc:1 NeuAc:1 Lactose Free G72506RN structure 1871

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

1922 Fuc(a1-2)Gal(b1-4)Glc Hex:2 dHex:1 Lactose Free G10422IZ structure 1922

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

2105 Gal(b1-4)Glc Hex:2 Lactose Free G74621DY structure 2105

    Protein

    Composition

  • Hex:2 (avg mass : 342.3001 )

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

2467 NeuAc(a2-3)Gal(b1-4)Glc Hex:2 NeuAc:1 Lactose Free G56516VH structure 2467

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

2501 NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-3)Gal(b1-4)Glc Hex:3 HexNAc:1 NeuAc:2 Lactose Free G38710SX structure 2501

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

2906 Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)]Gal(b1-4)Glc Hex:5 HexNAc:3 dHex:2 NeuAc:1 Lactose Free G75030WH structure 2906

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

2961 Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)]Gal(b1-4)Glc Hex:4 HexNAc:2 dHex:2 Lactose Free G42436GS structure 2961

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

3001 NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc Hex:3 HexNAc:1 NeuAc:1 Lactose Free G21066IE structure 3001

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

3051 Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc Hex:3 HexNAc:1 Lactose Free G48059CD structure 3051

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

3099 Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc Hex:3 HexNAc:1 dHex:1 Lactose Free G01650PH structure 3099

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

3150 Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)]Gal(b1-4)Glc Hex:5 HexNAc:3 dHex:2 NeuAc:1 Lactose Free G45570JA structure 3150

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

3242 Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-3)Gal(b1-4)Glc Hex:3 HexNAc:1 NeuAc:1 Lactose Free G19017MP structure 3242

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

3313 Fuc(a1-3)[Gal(b1-4)]Glc Hex:2 dHex:1 Lactose Free G06210XB structure 3313

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

3549 NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal Hex:2 HexNAc:1 dHex:1 NeuAc:1 Truncated Free G14561VC structure 3549

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8921 Neu5Ac(a2-3)[6S]Gal(b1-4)Glc(b1- Hex:2 NeuAc:1 Su:1 Lactose Free - - structure 8921

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8922 Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)][Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Glc(b1- Hex:3 HexNAc:1 dHex:1 NeuAc:2 Lactose Free - - structure 8922

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8923 - Hex:3 HexNAc:1 dHex:1 NeuAc:2 Lactose Free - - structure 8923

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8924 [Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:4 HexNAc:2 dHex:3 Lactose Free - - structure 8924
8925 [Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-6)][Neu5Ac(a2-3)Gal(b1-3)GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:4 HexNAc:2 NeuAc:2 Lactose Free - - structure 8925

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8926 [Gal(b1-4)GlcNAc(b1-6)][Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:4 HexNAc:2 NeuAc:2 Lactose Free - - structure 8926
8927 [Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-6)][Neu5Ac(a2-3)Gal(b1-3)[Neu5Ac(a2-6)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:4 HexNAc:2 NeuAc:3 Lactose Free - - structure 8927

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8928 [Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-6)][Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:4 HexNAc:2 NeuAc:2 Lactose Free - - structure 8928
8929 - Hex:4 HexNAc:2 dHex:3 Lactose Free - - structure 8929

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8930 [[Fuc(a1-2)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:5 HexNAc:3 dHex:3 NeuAc:1 Lactose Free - - structure 8930

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8931 [Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][Neu5Ac(a2-6)[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:5 HexNAc:3 dHex:1 NeuAc:2 Lactose Free - - structure 8931

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8932 [[Fuc(a1-2)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:5 HexNAc:3 dHex:4 Lactose Free - - structure 8932

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8933 [[Fuc(a1-2)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:5 HexNAc:3 dHex:5 Lactose Free - - structure 8933

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8934 [[Fuc(a1-2)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:5 HexNAc:3 dHex:4 Lactose Free - - structure 8934

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8935 [[[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)GlcNAc(b1-6)][Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:7 HexNAc:5 dHex:2 NeuAc:1 Lactose Free - - structure 8935

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8936 [[[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:7 HexNAc:5 dHex:3 Lactose Free - - structure 8936

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide

8937 [Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1- Hex:4 HexNAc:2 dHex:3 Lactose Free - - structure 8937

    Protein

    Disease

    Reported glycosite

    Mass spectrometry observed peptide